NCT07003438View on ClinicalTrials.gov

Study on the Efficacy and Safety of Fecal Microbiota Transplantation in the Treatment of Steroid - Dependent /Steroid-resistant Nephrotic Syndrome in Children

EARLY_PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

April 1, 2026

Study Completion Date

April 1, 2028

Conditions

Steroid-Resistant Nephrotic SyndromeSteroid-Dependent Nephrotic Syndrome

Interventions

DRUG

Fecal microbiota transplantation (FMT)

FMT was slowly administered to the patient's small intestine with fecal suspension under anesthesia and patients received a second transplant through oral administration freeze-dried capsules containing the fecal matter.

All Listed Sponsors

lead

Zhang Ting

OTHER